APAC In Vivo Preclinical Brain Imaging Devices Market - Industry Trends and Forecast to 2031

Description

List of Tables

The Asia-Pacific in vivo preclinical brain imaging devices market is expected to reach USD 135,157.77 thousand by 2030 from USD 91,151.10 thousand in 2022, growing at a CAGR of 5.1% in the forecast period of 2023 to 2030.

Market Segmentation

Asia-Pacific In Vivo Preclinical Brain Imaging Devices Market, By Imaging Modality Type (MRI, PET/SPECT, CT, Optical Miniscopes, 2Photon Confocal, US, NIR Fluorescence, OCT, Bioluminescence, and Others), Application (Drug Discovery, Disease Characterization, and Toxicology), Therapeutic Area (Alzheimer's Disease, Parkinson's Disease, Oncology, and Other Therapeutic Areas), Biological Variable (BOLD, Oxygenation, Blood Flow, Microvessels, Neuronal Activity, and Soft Tissue), Temporal Format of Use (Under an Hour, Many Hours, and Longitudinal) End User (Pharma-Inhouse, CRO, Academia, and Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2030.

Overview of Asia-Pacific In Vivo Preclinical Brain Imaging Devices Market Dynamics

Driver
Rising prevalence of neurological disorder
Restraint
Ethical and regulatory consideration
Opportunity
Rising research and development activities

Market Players

The key market players operating in the Asia-Pacific invivo preclinical brain imaging devices market are:

Bruker
PerkinElmer Inc.
FUJIFILM Corporation
Miltenyi Biotec
Charles River Laboratories.
Hologic, Inc.
LI-COR, Inc.
MILabs B.V.
TriFoil Imaging
Berthold Technologies GmbH & Co.KG
A14R
Aspect Imaging Ltd.
Cubresa Inc.
Mediso Ltd.
MR Solutions
Spectrum Instruments Imaging

1 INTRODUCTION 16

1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 OVERVIEW OF THE ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET 16
1.4 CURRENCY AND PRICING 17
1.5 LIMITATIONS 18
1.6 MARKETS COVERED 18

2 MARKET SEGMENTATION 20

2.1 MARKETS COVERED 20
2.2 GEOGRAPHICAL SCOPE 21
2.3 YEARS CONSIDERED FOR THE STUDY 22
2.4 DBMR TRIPOD DATA VALIDATION MODEL 23
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 26
2.6 MULTIVARIATE MODELLING 27
2.7 IMAGING MODALITY TYPE SEGMENT LIFELINE CURVE 27
2.8 MARKET END USER COVERAGE GRID 28
2.9 DBMR MARKET POSITION GRID 29
2.10 VENDOR SHARE ANALYSIS 31
2.11 SECONDARY SOURCES 32
2.12 ASSUMPTIONS 32

3 EXECUTIVE SUMMARY 33

4 PREMIUM INSIGHTS 36

4.1 PESTEL ANALYSIS 37
4.2 PORTR'S FIVE FORCES 38

5 REGULATORY FRAMEWORK 39

5.1 REGULATORY SCENARIO IN U.S. 39
5.2 REGULATORY SCENARIO IN AUSTRALIA 39
5.3 REGULATORY SCENARIO IN EUROPE 40
5.4 REGULATORY SCENARIO IN SOUTH AFRICA 40
5.5 REGULATORY SCENARIO IN BRAZIL 40

6 MARKET OVERVIEW 41

6.1 DRIVERS 43
- 6.1.1 RISING PREVALENCE OF NEUROLOGICAL DISORDERS 43
- 6.1.2 ADVANCEMENTS IN IMAGING TECHNIQUES USED IN BRAIN IMAGING 43
- 6.1.3 INCREASING ADOPTION OF IN-VIVO IMAGING SYSTEMS 44
6.2 RESTRAINTS 44
- 6.2.1 ETHICAL AND REGULATORY CONSIDERATIONS 44
- 6.2.2 HIGH COST ASSOCIATED WITH BRAIN IMAGING EQUIPMENT 44
6.3 OPPORTUNITIES 45
- 6.3.1 RISING STRATEGIC INITIATIVES BY THE KEY MARKET PLAYERS 45
- 6.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES 45
6.4 CHALLENGES 46
- 6.4.1 LACK OF SKILLED PROFESSIONALS DUE TO TECHNOLOGY ADVANCEMENT 46
- 6.4.2 INTEGRATION OF IMAGING DEVICES WITH OTHER TECHNOLOGIES 47

7 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE 48

7.1 OVERVIEW 49
7.2 MRI 50
7.3 PET/SPECT 51
7.4 CT 51
7.5 OPTICAL MINISCOPES 52
7.6 2 PHOTON CONFOCAL 52
7.7 US 53
7.8 NIR FLUORESCENCE 53
7.9 OCT 54
7.10 BIOLUMINESCENCE 54
7.11 OTHERS 55

8 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION 56

8.1 OVERVIEW 57
8.2 DRUG DISCOVERY 58
- 8.2.1 PRECLINICAL STUDIES 59
- 8.2.2 EARLY DRUG DISCOVERY 59
- 8.2.3 CLINICAL DEVELOPMENT 59
- 8.2.4 POST MARKET MONITORING 59
- 8.2.5 DATA REVIEW 59
8.3 DISEASE CHARACTERIZATION 59
8.4 TOXICOLOGY 60

9 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA 61

9.1 OVERVIEW 62
9.2 ALZHEIMER'S DISEASE 63
9.3 PARKINSON'S DISEASE 64
9.4 ONCOLOGY 64
9.5 OTHER THERAPEUTIC AREAS 65

10 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 66

10.1 OVERVIEW 67
10.2 BOLD 68
10.3 OXYGENATION 69
10.4 BLOOD FLOW 69
10.5 MICROVESSELS 70
10.6 NEURONAL ACTIVITY 70
10.7 SOFT TISSUE 71

11 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE 72

11.1 OVERVIEW 73
11.2 UNDER AN HOUR 74
11.3 MANY HOURS 75
11.4 LONGITUDINAL 75

12 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER 76

12.1 OVERVIEW 77
12.2 PHARMA-INHOUSE 78
12.3 CRO 79
12.4 ACADEMIA 79
12.5 OTHERS 80

13 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION 81

13.1 ASIA-PACIFIC 82

14 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, COMPANY LANDSCAPE 106

14.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 106

15 SWOT ANALYSIS 107

16 COMPANY PROFILE 108

16.1 BRUKER 108
- 16.1.1 COMPANY SNAPSHOT 108
- 16.1.2 REVENUE ANALYSIS 108
- 16.1.3 COMPANY SHARE ANALYSIS 109
- 16.1.4 PRODUCT PORTFOLIO 109
- 16.1.5 RECENT DEVELOPMENT 109
16.2 PERKINELMER INC. 110
- 16.2.1 COMPANY SNAPSHOT 110
- 16.2.2 REVENUE ANALYSIS 110
- 16.2.3 COMPANY SHARE ANALYSIS 111
- 16.2.4 PRODUCT PORTFOLIO 111
- 16.2.5 RECENT DEVELOPMENT 111
16.3 FUJIFILM CORPORATION 112
- 16.3.1 COMPANY SNAPSHOT 112
- 16.3.2 REVENUE ANALYSIS 112
- 16.3.3 COMPANY SHARE ANALYSIS 113
- 16.3.4 PRODUCT PORTFOLIO 113
- 16.3.5 RECENT DEVELOPMENT 113
16.4 MILTENYI BIOTEC 114
- 16.4.1 COMPANY SNAPSHOT 114
- 16.4.2 COMPANY SHARE ANALYSIS 114
- 16.4.3 PRODUCT PORTFOLIO 115
- 16.4.4 RECENT DEVELOPMENT 115
16.5 CHARLES RIVER LABORATORIES. 116
- 16.5.1 COMPANY SNAPSHOT 116
- 16.5.2 REVENUE ANALYSIS 116
- 16.5.3 COMPANY SHARE ANALYSIS 117
- 16.5.4 PRODUCT PORTFOLIO 117
- 16.5.5 RECENT DEVELOPMENT 117
16.6 AI4R 118
- 16.6.1 COMPANY SNAPSHOT 118
- 16.6.2 PRODUCT PORTFOLIO 118
- 16.6.3 RECENT DEVELOPMENT 118
16.7 ASPECT IMAGING LTD. 119
- 16.7.1 COMPANY SNAPSHOT 119
- 16.7.2 PRODUCT PORTFOLIO 119
- 16.7.3 RECENT DEVELOPMENT 119
16.8 BERTHOLD TECHNOLOGIES GMBH & CO.KG 120
- 16.8.1 COMPANY SNAPSHOT 120
- 16.8.2 PRODUCT PORTFOLIO 120
- 16.8.3 RECENT DEVELOPMENT 120
16.9 CUBRESA INC. 121
- 16.9.1 COMPANY SNAPSHOT 121
- 16.9.2 PRODUCT PORTFOLIO 121
- 16.9.3 RECENT DEVELOPMENT 121
16.10 HOLOGIC, INC. 122
- 16.10.1 COMPANY SNAPSHOT 122
- 16.10.2 REVENUE ANALYSIS 122
- 16.10.3 PRODUCT PORTFOLIO 123
- 16.10.4 RECENT DEVELOPMENT 123
16.11 LI-COR, INC. 124
- 16.11.1 COMPANY SNAPSHOT 124
- 16.11.2 PRODUCT PORTFOLIO 124
- 16.11.3 RECENT DEVELOPMENT 124
16.12 MEDISO LTD. 125
- 16.12.1 COMPANY SNAPSHOT 125
- 16.12.2 PRODUCT PORTFOLIO 125
- 16.12.3 RECENT DEVELOPMENT 125
16.13 MILABS B.V. 126
- 16.13.1 COMPANY SNAPSHOT 126
- 16.13.2 PRODUCT PORTFOLIO 126
- 16.13.3 RECENT DEVELOPMENT 126
16.14 MR SOLUTIONS 127
- 16.14.1 COMPANY SNAPSHOT 127
- 16.14.2 PRODUCT PORTFOLIO 127
- 16.14.3 RECENT DEVELOPMENT 127
16.15 SPECTRAL INSTRUMENTS IMAGING 128
- 16.15.1 COMPANY SNAPSHOT 128
- 16.15.2 PRODUCT PORTFOLIO 128
- 16.15.3 RECENT DEVELOPMENT 128
16.16 TRIFOIL IMAGING 129
- 16.16.1 COMPANY SNAPSHOT 129
- 16.16.2 PRODUCT PORTFOLIO 129
- 16.16.3 RECENT DEVELOPMENT 129

17 QUESTIONNAIRE 130

18 RELATED REPORTS 133

LIST OF TABLES

TABLE 1 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 50
TABLE 2 ASIA-PACIFIC MRI IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 50
TABLE 3 ASIA-PACIFIC PET/SPECT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 51
TABLE 4 ASIA-PACIFIC CT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 51
TABLE 5 ASIA-PACIFIC OPTICAL MINISCOPES IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 52
TABLE 6 ASIA-PACIFIC 2 PHOTON CONFOCAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 52
TABLE 7 ASIA-PACIFIC US IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 53
TABLE 8 ASIA-PACIFIC NIR FLUORESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 53
TABLE 9 ASIA-PACIFIC OCT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 54
TABLE 10 ASIA-PACIFIC BIOLUMINESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 54
TABLE 11 ASIA-PACIFIC OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 55
TABLE 12 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 58
TABLE 13 ASIA-PACIFIC DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 58
TABLE 14 ASIA-PACIFIC DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 58
TABLE 15 ASIA-PACIFIC DISEASE CHARACTERIZATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 59
TABLE 16 ASIA-PACIFIC TOXICOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 60
TABLE 17 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 63
TABLE 18 ASIA-PACIFIC ALZHEIMER'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 63
TABLE 19 ASIA-PACIFIC PARKINSON'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 64
TABLE 20 ASIA-PACIFIC ONCOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 64
TABLE 21 ASIA-PACIFIC OTHER THERAPEUTIC AREAS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 65
TABLE 22 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 68
TABLE 23 ASIA-PACIFIC BOLD IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 68
TABLE 24 ASIA-PACIFIC OXYGENATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 69
TABLE 25 ASIA-PACIFIC BLOOD FLOW IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 69
TABLE 26 ASIA-PACIFIC MICROVESSELS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 70
TABLE 27 ASIA-PACIFIC NEURONAL ACTIVITY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 70
TABLE 28 ASIA-PACIFIC SOFT TISSUE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 71
TABLE 29 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 74
TABLE 30 ASIA-PACIFIC UNDER AN HOUR IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 74
TABLE 31 ASIA-PACIFIC MANY HOURS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 75
TABLE 32 ASIA-PACIFIC LONGITUDINAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 75
TABLE 33 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 78
TABLE 34 ASIA-PACIFIC PHARMA-INHOUSE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 78
TABLE 35 ASIA-PACIFIC CRO IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 79
TABLE 36 ASIA-PACIFIC ACADEMIA IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 79
TABLE 37 ASIA-PACIFIC OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 80
TABLE 38 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 82
TABLE 39 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 82
TABLE 40 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 83
TABLE 41 ASIA-PACIFIC DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 83
TABLE 42 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 83
TABLE 43 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 83
TABLE 44 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 84
TABLE 45 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 84
TABLE 46 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 85
TABLE 47 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 85
TABLE 48 JAPAN DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 85
TABLE 49 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 86
TABLE 50 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 86
TABLE 51 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 86
TABLE 52 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 86
TABLE 53 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 87
TABLE 54 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 87
TABLE 55 CHINA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 87
TABLE 56 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 88
TABLE 57 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 88
TABLE 58 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 88
TABLE 59 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 88
TABLE 60 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 89
TABLE 61 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 89
TABLE 62 SOUTH KOREA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 89
TABLE 63 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 90
TABLE 64 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 90
TABLE 65 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 90
TABLE 66 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 90
TABLE 67 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 91
TABLE 68 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 91
TABLE 69 INDIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 91
TABLE 70 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 92
TABLE 71 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 92
TABLE 72 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 92
TABLE 73 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 92
TABLE 74 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 93
TABLE 75 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 93
TABLE 76 AUSTRALIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 93
TABLE 77 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 94
TABLE 78 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 94
TABLE 79 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 94
TABLE 80 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 94
TABLE 81 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 95
TABLE 82 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 95
TABLE 83 SINGAPORE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 95
TABLE 84 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 96
TABLE 85 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 96
TABLE 86 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 96
TABLE 87 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 96
TABLE 88 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 97
TABLE 89 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 97
TABLE 90 THAILAND DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 97
TABLE 91 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 98
TABLE 92 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 98
TABLE 93 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 98
TABLE 94 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 98
TABLE 95 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 99
TABLE 96 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 99
TABLE 97 MALAYSIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 99
TABLE 98 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 100
TABLE 99 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 100
TABLE 100 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 100
TABLE 101 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 100
TABLE 102 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 101
TABLE 103 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 101
TABLE 104 INDONESIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 101
TABLE 105 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 102
TABLE 106 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 102
TABLE 107 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 102
TABLE 108 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 102
TABLE 109 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 103
TABLE 110 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 103
TABLE 111 PHILIPPINES DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 103
TABLE 112 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 104
TABLE 113 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 104
TABLE 114 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 104
TABLE 115 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 104
TABLE 116 REST OF ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 105

LIST OF FIGURES

FIGURE 1 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SEGMENTATION 20
FIGURE 2 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DATA TRIANGULATION 23
FIGURE 3 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DROC ANALYSIS 24
FIGURE 4 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS 25
FIGURE 5 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY RESEARCH ANALYSIS 25
FIGURE 6 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: INTERVIEW DEMOGRAPHICS 26
FIGURE 7 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: MARKET END USERS COVERAGE GRID 28
FIGURE 8 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DBMR MARKET POSITION GRID 29
FIGURE 9 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: VENDOR SHARE ANALYSIS 31
FIGURE 10 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SEGMENTATION 35
FIGURE 11 RISING PREVALENCE OF NEUROLOGICAL DISORDER IS EXPECTED TO DRIVE THE GROWTH OF THE ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET FROM 2023 TO 2030 36
FIGURE 12 IMAGING MODALITY TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET IN 2023 & 2030 36
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET 42
FIGURE 14 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY IMAGING MODALITY TYPE, 2022 49
FIGURE 15 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY APPLICATION, 2022 57
FIGURE 16 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY THERAPEUTIC AREA, 2022 62
FIGURE 17 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY BIOLOGICAL VARIABLE, 2022 67
FIGURE 18 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY TEMPORAL FORMAT OF USE, 2022 73
FIGURE 19 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY END USER, 2022 77
FIGURE 20 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%) 106